KP
Kurma Partners
Venture CapitalActiveKurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology.
63
Investments
7
Exits
$500M
AUM
11.1%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Kurma Partners.
Investment Thesis & Strategy
Kurma Partners invests in various stages of biotech, fintech, healthcare, health diagnostics, and life science companies, with a focus on financing innovation in these sectors.
Investment Activity
Deals per year over the last 6 years
3
20141
20155
20161
20171
20181
2019Portfolio Companies
Selected investments from their portfolio of 63 companies
D
DNA Script
Biotech · Series B, 2019
E
Echosens
Healthcare · Growth, 2018
I
ImCheck Therapeutics
Biotech · Series A, 2017
C
Cardiawave
Biotech · Series A, 2016
I
Incepto
Healthcare · Series A, 2016
A
Atawey
Cleantech · Series A, 2016
B
BioSerenity
Healthcare · Series A, 2016
M
MaaT Pharma
Biotech · Series A, 2016
O
OSE Immunotherapeutics
Biotech · Series A, 2015
E
Enterome
Biotech · Series A, 2014
P
Pixium Vision
Biotech · Series A, 2014
H
Horama
Biotech · Series A, 2014
Notable Exits
CompanyTypeYearValue / Acquirer
EnteromeAcquisition2024—
AbivaxIPO2018—
AdociaIPO2014—
Pixium VisionIPO2014—
DBV TechnologiesIPO2014$360M
CarmatIPO2010—
Innate PharmaIPO2006—
Frequently Asked Questions
Kurma Partners focuses on Series A, Series B, Series C+ stage investments.